1541195-53-2

Basic information

• Product Name: (2S,3S,4R)-2-amino-1-O-(α-D-galactopyranosyl)-4-O-(hexacosanoyl)octadecane-1,3,4-triol
• Synonyms: (2S,3S,4R)-2-amino-1-O-(α-D-galactopyranosyl)-4-O-(hexacosanoyl)octadecane-1,3,4-triol
• CAS NO: 1541195-53-2
• Molecular Weight: 858.337
• Mol File: 1541195-53-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (2S,3S,4R)-2-amino-1-O-(α-D-galactopyranosyl)-4-O-(hexacosanoyl)octadecane-1,3,4-triol(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,3S,4R)-2-amino-1-O-(α-D-galactopyranosyl)-4-O-(hexacosanoyl)octadecane-1,3,4-triol(1541195-53-2)
• EPA Substance Registry System: (2S,3S,4R)-2-amino-1-O-(α-D-galactopyranosyl)-4-O-(hexacosanoyl)octadecane-1,3,4-triol(1541195-53-2)

Safety Data

• Hazardous Substances Data: 1541195-53-2(Hazardous Substances Data)

Upstream product

• 1613320-91-4 (2S,3S,4R)-3,4-O-dibenzyl-1-O-α-D-galactopyranosyl-2-hexacosanoylaminooctadec-6-ene-1,3,4-triol 

Downstream Products

• 1613321-09-7 (2S,3S,4R)-1-O-(α-D-galactopyranosyl)-4-O-(hexacosanoyl)-2-(((N-levulinoyl-Val-Cit-4-aminobenzyloxy)carbonyl)amino)octadecane-1,3,4-triol 
• 1613321-11-1 (2S,3S,4R)-2-(N-((9H-fluoren-9-yl)methoxycarbonyl)-L-valinyl-L-citrullinyl-4-am inobenzyloxycarbonylamino)-1-(δ-D-galactopyranosyloxy)-3-hydroxyoctadecan-4-yl hexacosanoate 
• 1613321-10-0 (2S,3S,4R)-1-O-(α-D-galactopyranosyl)-3-O-(hexacosanoyl)-2-(((N-levulinoyl-Val-Cit-4-aminobenzyloxy)carbonyl)amino)octadecane-1,3,4-triol 
• 1613321-06-4 (2S,3S,4R)-1-O-(α-D-galactopyranosyl)-4-O-(hexacosanoyl)-2-(((N-(5-hexenoyl)-Val-Cit-4-aminobenzyloxy)carbonyl)amino)octadecane-1,3,4-triol 
• 1613321-03-1 (2S,3S,4R)-1-O-(α-D-galactopyranosyl)-4-O-(hexacosanoyl)-2-(((N-(6-azidohexanoyl)-Val-Cit-4-aminobenzyloxy)carbonyl)amino)octadecane-1,3,4-triol 
• 1613321-00-8 (2S,3S,4R)-1-O-(α-D-galactopyranosyl)-4-O-(hexacosanoyl)-2-(((N-Cbz-Val-Cit-4-aminobenzyloxy)carbonyl)amino)octadecane-1,3,4-triol 
• 1613320-97-0 (2S,3S,4R)-1-O-(α-D-galactopyranosyl)-4-O-(hexacosanoyl)-2-[N-Cbz-Phe-Lys(ε-Alloc)-((4-aminobenzyloxy)carbonyl)amino]octadecane-1,3,4-triol 
• 1541195-94-1 (2S,3S,4R)-1-O-α-D-galactopyranosyl-4-hexacosanoyl-2-(3-(2-acetoxy-4,6-dimethylphenyl)-3,3-dimethylpropionoylamino)octadecane-1,3,4-triol 
• 1541195-81-6 (2S,3S,4R)-1-O-α-D-galactopyranosyl-4-hexacosanoyl-2-((4-nitrobenzoyloxy)methoxycarbonylamino)octadecane-1,3,4-triol 
• 1541195-78-1 (2S,3S,4R)-1-O-α-D-galactopyranosyl-4-hexacosanoyl-2-((4-methoxybenzoyloxy)methoxycarbonylamino) octadecane-1,3,4-triol 
• 1541195-71-4 (2S,3S,4R)-2-(benzoyloxymethoxycarbonylamino)-1-O-α-D-galactopyranosyl-4-hexacosanoyloctadecane-1,3,4-triol 
• 1541195-67-8 (2S,3S,4R)-2-((2-(benzyloxycarbonylamino)acetoxy)methoxycarbonylamino)-1-O-α-D-galactopyranosyl-4-hexacosanoyloctadecane-1,3,4-triol 
• 1541195-55-4 C₆₆H₁₁₄NO₁₅P 

Relevant articles and documents

NKT cell-dependent glycolipid-peptide vaccines with potent anti-tumour activity

It is known that T cells can eliminate tumour cells through recognition of unique or aberrantly expressed antigens presented as peptide epitopes by major histocompatibility complex (MHC) molecules on the tumour cell surface. With recent advances in defini